XML 112 R104.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Financial Information by Quarter (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues:                      
Product, net $ 100,113 $ 99,041 $ 94,668 $ 87,011 $ 84,415 $ 78,486 $ 73,529 $ 64,604 $ 380,833 $ 301,034 $ 154,584
Type of Revenue [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Total revenues $ 100,113 $ 99,041 $ 94,668 $ 87,011 $ 84,415 $ 78,486 $ 73,529 $ 64,604 $ 380,833 $ 301,034 $ 154,584
Cost and expenses:                      
Cost of sales (excluding amortization of in-licensed rights) 15,567 13,037 15,919 12,063 13,135 8,741 6,735 5,582 56,586 34,193 7,353
Research and development expense 223,141 133,949 113,266 90,553 146,207 86,584 122,848 46,204      
Selling, general and administrative 81,424 75,429 67,393 60,566 64,220 53,044 47,156 43,341 284,812 207,761 122,682
Acquired in-process research and development     173,240           173,240    
Settlement and license charges 10,000               10,000   28,427
Amortization of in-licensed rights 200 216 217 216 216 216 217 216 849 865 1,053
Total cost and expenses 330,332 222,631 370,035 163,398 223,778 148,585 176,956 95,343 1,086,396 644,662 326,222
Operating loss (230,219) (123,590) (275,367) (76,387) (139,363) (70,099) (103,427) (30,739) (705,563) (343,628) (171,638)
Other (loss) income:                      
Other expense, net (4,773) (2,510) (862) (172)              
Total other (loss) income (4,773) (2,510) (862) (172) (2,311) (6,968) (5,218) (4,485) (8,317) (18,982) 123,010
Interest expense and other, net         (2,311) (6,968) (5,218) (4,485)      
Loss before income tax expense (benefit) (234,992) (126,100) (276,229) (76,559) (141,674) (77,067) (108,645) (35,224) (713,880) (362,610) (48,628)
Income tax expense (benefit) 711 226 174 84 (779) (674) 622 139 1,195 (692) 2,060
Gain from sale of Priority Review Voucher                     125,000
Net loss $ (235,703) $ (126,326) $ (276,403) $ (76,643) $ (140,895) $ (76,393) $ (109,267) $ (35,363) $ (715,075) $ (361,918) $ (50,688)
Net loss per share — basic and diluted $ (3.16) $ (1.70) $ (3.74) $ (1.07) $ (2.05) $ (1.15) $ (1.67) $ (0.55) $ (9.71) $ (5.46) $ (0.86)
Weighted average number of shares of common stock used in computing basic and diluted net loss per share 74,557 74,177 73,958 71,731 68,653 66,209 65,484 64,631 73,615,000 66,250,000 58,818,000